RxSight ex-director to sell 11,890 shares

RxSight, Inc. (RXST) received a notice under Rule 144 that former director Raymond W. Cohen intends to sell 11,890 shares of common stock.

Rhea-AI Filing Summary

RxSight, Inc. (RXST) received a notice under Rule 144 that former director Raymond W. Cohen intends to sell 11,890 shares of common stock. The proposed sale, with an indicated value of $75,748.81, is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

Key Figures

Shares proposed for sale: 11,890 shares Aggregate value of proposed sale: $75,748.81 Proposed sale date: 08/18/2026 +2 more

5 metrics

Shares proposed for sale 11,890 shares Common stock covered by the Rule 144 notice for Raymond W. Cohen

Aggregate value of proposed sale $75,748.81 Reported value associated with 11,890 RxSight common shares

Proposed sale date 08/18/2026 Date associated with the planned NASDAQ sale of the shares

Security type Common, Restricted Stock Type of RxSight securities to be sold under Rule 144

Broker Morgan Stanley Smith Barney LLC Firm designated to execute the proposed sale on NASDAQ

Key Terms

Rule 144, Restricted Stock, Form 144, Issuer

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 07/31/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer financial

"Restricted Stock | Issuer | | | 11890"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for RxSight, Inc. (RXST)?

The filing indicates that former director Raymond W. Cohen plans to sell 11,890 shares of RxSight common stock under Rule 144. This is a disclosure of a potential insider sale, not a company-led transaction or capital raise.

How many RxSight (RXST) shares are proposed to be sold in this Form 144?

The notice covers a proposed sale of 11,890 shares of RxSight common stock. These shares are described as Restricted Stock, eligible for resale under Rule 144, subject to the applicable conditions being satisfied.

What is the approximate value of the RxSight (RXST) shares covered by this Form 144?

The filing lists an aggregate value of $75,748.81 for the 11,890 RxSight shares. This figure reflects the reference market price used in the notice and provides an estimate of the transaction’s size for disclosure purposes.

Who is selling RxSight (RXST) shares according to this Form 144?

The proposed sale is for the account of Raymond W. Cohen, identified as a former director of RxSight, Inc. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

On which market will the RxSight (RXST) Form 144 shares be sold?

The notice states that the 11,890 RxSight common shares are expected to be sold on NASDAQ. The broker named is Morgan Stanley Smith Barney LLC, which will handle the execution of the proposed Rule 144 transaction.

What type of RxSight (RXST) securities are included in this Form 144?

The securities consist of common stock classified as Restricted Stock, originally acquired from the issuer. The Form 144 indicates these restricted shares are being proposed for resale under the Rule 144 framework.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:45 PM Accepted by SEC EDGAR 08/18/2026 - 05:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001258288
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RXSIGHT, INC.
SEC File Number	001-40690
Address of Issuer	100 Columbia Aliso Viejo CALIFORNIA 92656
Phone	(949) 521-7830
Name of Person for Whose Account the Securities are To Be Sold	RAYMOND W COHEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11890	75748.81	41593256	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2026	Restricted Stock	Issuer			11890	07/31/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Raymond W Cohen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)